Related Experiment Video
Updated: Jun 7, 2026
05:39
A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
Published on: November 30, 2021
Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis
Hala Chaaban1, Michael Shin, Edward Sirya
1Department of Pediatrics, Women & Infants Hospital, Brown Medical School, Providence, RI 02905, USA.
The Journal of Pediatrics
|October 20, 2010
Summary
Inter-alpha inhibitor protein (IaIp) levels were significantly lower in neonates with necrotizing enterocolitis (NEC). This suggests IaIp may serve as a sensitive biomarker for early NEC detection and management in newborns.
Area of Science:
- Neonatal intensive care
- Biomarker discovery
- Gastroenterology
Background:
- Necrotizing enterocolitis (NEC) is a severe gastrointestinal condition in neonates.
- Early diagnosis of NEC is crucial for effective treatment and improved outcomes.
- Inter-alpha inhibitor protein (IaIp) is a protein involved in inflammatory processes.
Purpose of the Study:
- To compare plasma IaIp levels in neonates with confirmed NEC versus those with other abdominal disorders.
- To evaluate the potential of IaIp as a biomarker for NEC.
Main Methods:
- Prospective observational study in a neonatal intensive care unit.
- Diagnosis of NEC based on Bell's staging criteria.
- Plasma IaIp levels measured using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- Seventeen neonates had confirmed NEC, and 34 had nonspecific abdominal disorders.
- No significant differences in demographic or obstetric factors between groups.
- Mean IaIp level was significantly lower in the NEC group (137 ± 38 mg/L) compared to the control group (258 ± 53 mg/L; P <.0001).
Conclusions:
- Lower IaIp levels in neonates with NEC indicate its potential as a sensitive biomarker.
- IaIp measurement could aid in early NEC detection, guiding therapy and reducing antibiotic overuse.
- IaIp administration may mitigate systemic inflammation and tissue injury in NEC.
